Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Davictrel vs Enbrel in Rheumatoid Arthritis
NCT01270997Phase 3Completed
- Sponsor
- Hanwha Solutions Chemical Division
- Start
- Dec 2010
- Primary completion
- May 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Davictrel in rheumatoid arthritis (RA), sponsored by Hanwha Solutions Chemical Division. Started Dec 2010; status: completed.
02
Drugs
Davictrel
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01270997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270997.